Pharvaris reports Q2 loss of €47.8 million
Pharvaris incurred a loss of €47.8 million in Q2, resulting in a basic and diluted loss per share of €0.70.
The loss for the quarter ended June 30, 2026, compares to a loss of €45.5 million in the same period last year.
The prior year’s loss translated to a basic and diluted loss per share of €0.83 for the quarter ended June 30, 2025.